Nurix Therapeutics Inc

NASDAQ:NRIX   3:59:41 PM EDT
27.50
+0.59 (+2.19%)
Other Pre-Announcement

Nurix Therapeutics Q3 Loss Per Share $0.59

Published: 10/14/2020 22:35 GMT
(NRIX) - Nurix Therapeutics Reports Third Quarter Fiscal 2020 Financial Results and Provides a Corporate Update.
Q3 Loss per Share $0.59.
Q3 Earnings per Share Estimate $-0.41 -- Refinitiv Ibes Data (analyst estimates).
On Track for Multiple Ind Filings.
Collaboration Revenue for Three Months Ended August 31, 2020 Was $4.1 Million Versus $10.6 Million.
As of August 31, 2020, Company Had Cash, Cash Equivalents and Investments of $395.1 Million.